Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 301 AL 315

Reducing the Effects of Ageing on Cognition with Therapeutic Intervention of an Oral Multi-Nutrient: The REACTION Pilot Trial Study Design

Camargo CJ, Merritt S, Modjeski M, Counotte DS, Fernández McInerney K.

J Prev Alzheimers Dis. 2023;10(4):821-827. doi: 10.14283/jpad.2023.81.

Tau-targeting therapies for Alzheimer disease: current status and future directions

Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM.

Nat Rev Neurol. 2023 Dec;19(12):715-736. doi: 10.1038/s41582-023-00883-2. Epub 2023 Oct 24.

The Role of Oxytocin in Alzheimer's Disease and Its Relationship with Social Interaction

Takahashi J, Yamada D, Nagano W, Saitoh A.

Cells. 2023 Oct 10;12(20):2426. doi: 10.3390/cells12202426.

The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease

Trojan V, Landa L, Šulcová A, Slíva J, Hřib R.

Biomolecules. 2023 Sep 26;13(10):1446. doi: 10.3390/biom13101446.

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design

Tundo GR, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A, Marini S, Parravano M, Graziani G, Fattorusso C, Sbardella D.

Biomolecules. 2023 Oct 7;13(10):1492. doi: 10.3390/biom13101492.

Ethnic, Botanic, Phytochemistry and Pharmacology of the Acorus L. Genus: A Review

Zhao Y, Li J, Cao G, Zhao D, Li G, Zhang H, Yan M.

Molecules. 2023 Oct 16;28(20):7117. doi: 10.3390/molecules28207117.

The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease

Mehta N, Dangas K, Ditmarsch M, Rensen PCN, Dicklin MR, Kastelein JJP.

Pharmacol Res. 2023 Nov;197:106972. doi: 10.1016/j.phrs.2023.106972. Epub 2023 Oct 28.

GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports

Ingannato A, Bessi V, Chiari A, Salvatori D, Bagnoli S, Bedin R, Ferrari C, Sorbi S, Nacmias B.

J Alzheimers Dis. 2023;96(2):767-775. doi: 10.3233/JAD-230689.

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review

Chowdhury S, Chowdhury NS.

Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231209839. doi: 10.1177/03946320231209839.

Network pharmacology and molecular docking approaches predict the mechanisms of Corididius chinensis in treating manganese-induced nervous system diseases: A review

Zhang M, Lou H, Ma J, Xiong K, Hou X.

Medicine (Baltimore). 2023 Oct 27;102(43):e35669. doi: 10.1097/MD.0000000000035669.

Differential roles of regulatory T cells in Alzheimer's disease

Jafarzadeh A, Sheikhi A, Jafarzadeh Z, Nemati M.

Cell Immunol. 2023 Nov-Dec;393-394:104778. doi: 10.1016/j.cellimm.2023.104778. Epub 2023 Oct 29.

Passive Immunotherapies Targeting Amyloid-β in Alzheimer's Disease: A Quantitative Systems Pharmacology Perspective

Marković M, Milošević J, Wang W, Cao Y.

Mol Pharmacol. 2023 Dec 15;105(1):1-13. doi: 10.1124/molpharm.123.000726.

Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics

Lepiarz-Raba I, Gbadamosi I, Florea R, Paolicelli RC, Jawaid A.

Transl Neurodegener. 2023 Oct 31;12(1):48. doi: 10.1186/s40035-023-00382-w.

The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges

He J, Liu F, Xu T, Ma J, Yu H, Zhao J, Xie Y, Luo L, Yang Q, Lou T, He L, Sun D.

Biomed Pharmacother. 2023 Dec;168:115807. doi: 10.1016/j.biopha.2023.115807. Epub 2023 Oct 30.

Evaluation of clinical benefits of treatments for Alzheimer's disease

Liu KY, Walsh S, Brayne C, Merrick R, Richard E, Howard R.

Lancet Healthy Longev. 2023 Nov;4(11):e645-e651. doi: 10.1016/S2666-7568(23)00193-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias